Search results :

V 1784

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: L04AD01, S01XA18

Side effects

Options: Show MedDRA Preferred Terms,   display all 29 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Hirsutism postmarketing, 1% - 45% x x x x x x x x x x x x x x x x
Urinary tract infection postmarketing, 0% - 21.1% 0% x x x x x x x x x x x
Viral infection postmarketing, 15.9% - 18.4% x x x x x x x x x x x x
Hyperlipidaemia postmarketing, very common x x x x x x x x x x
Tremor postmarketing — 0% - 55% 4% x x x x x x x x x x x x x x x x x x
Sensation of heat 7.53% - 11.1% x x
Oedema postmarketing — 1% - 31.1% 1% x x x x x x x x x x x x x x x x x x
Fungal infection postmarketing, 7.5% - 9.6% x x x x x x x x x x x x
Skin infection 7% - 10.1% x x x x x x x x x x x
Wound 7% - 10.1% x x x x x x x x x x x
Pneumonia postmarketing, 0% - 9.2% 1% x x x x x x x x x x x
Pain postmarketing, 3.2% - 15.6% 4% x x x x x x
Nephropathy toxic 0% - 5.7% x x x x x x x x x x x x
Septicemia 4.8% - 5.3% x x x x x x x x x x x
Amenorrhoea common x x
Dysmenorrhoea common x x
Gingival hyperplasia postmarketing — 0% - 16% 1% x x x x x x x x x x x x x x x x x x
Infection susceptibility increased common x x
Fluid retention common x x
Abscess postmarketing, 4.4% - 5.3% x x x x x x x x x x x x
Nausea postmarketing — 1% - 23% 14% x x x x x x x x x x x x x x x x x x
Vomiting postmarketing — 1% - 15.6% 5% x x x x x x x x x x x x x x x x x x
Anorexia postmarketing — 3% 3% x x x x x x x x x x x x x x x x x x
Diarrhoea postmarketing — 1% - 13% 8% x x x x x x x x x x x x x x x x x x
Fatigue postmarketing — 3% - 8% 7% x x x x x x x x x x
Sinusitis postmarketing, 0% - 7% 3% x x x x x x x x x x x x x
Systemic mycosis 2.2% - 3.9% x x x x x x x x x x x
Headache postmarketing — 1% - 25% 9% x x x x x x x x x x x x x x x x x x
Cramp muscle common, 0% - 4% x x x x x x x x x x x x x x x
Acne postmarketing, 1% - 8% x x x x x x x x x x x x x
Nephrosis lower nephron 0% - 2.6% x x x x x x x x x x x x
Paraesthesia postmarketing — 0% - 11.1% 1% x x x x x x x x x x x x x x x x
Convulsion postmarketing — 1% - 5% x x x x x x x x x x x x x x x x x x
Rigors postmarketing, 1% - 4% 1% x x x x
Cerebellar ataxia postmarketing, uncommon x x x x x x
Coma postmarketing, uncommon x x x x x x
Paresis postmarketing, uncommon x x x x x x
Thrombocytopenia postmarketing, uncommon x x x x x x x x x x x x x x x x x x
Encephalopathy postmarketing, uncommon x x x x x x
Agitation postmarketing, uncommon x x x x x x
Blindness cortical postmarketing, uncommon x x x x x x
Disorientation postmarketing, uncommon x x x x x x
Visual disturbance postmarketing, uncommon x x x x x x x x x x x x x x x x x x
Hearing impaired uncommon x x x x x x x x x x x x x x
Gynaecomastia postmarketing — 0% - 4% x x x x x x x x x x x x x x x x x
Leukopenia postmarketing — 0% - 19% x x x x x x x x x x x x x x x x
Lymphoma 0% - 6% x x x x x x x x x x x x x
Hepatotoxicity postmarketing, 1% - 7% x x x x x x x x x x x x x x x
Lymphoproliferative disorder 0% - 0.4% x x x x x x x x x x x x x x x
Abdominal discomfort postmarketing, 0% - 7% x x x x x x x x x x x x x x
Abdominal distension postmarketing x x x x x
Abdominal pain postmarketing — 2.7% - 15% 10% x x x x x x x x
Pancreatitis acute postmarketing x x x x
Alopecia postmarketing, 0% - 4% 4% x x x x x x
Anaemia postmarketing — common x x x x x x x x x x x x x x x x x x
Angioedema postmarketing x x x x x x
Anxiety postmarketing x x x x x x x x x x x x
Arrhythmia postmarketing, 2% - 5% 1% x x x x
Arthralgia postmarketing, 1.1% - 6% x x x x x x x x x x x x
Rheumatoid arthritis postmarketing x x
Asthenia postmarketing x x x x x x x x x x x x x x
Bacterial infection postmarketing x x x x x
Mental disorder postmarketing x x x x x x
Coagulopathy postmarketing x x x x x
Breast disorder postmarketing x x x x x
Bronchospasm postmarketing, 4.9% - 5% x x x x x
Bronchitis postmarketing, 1% - 3% 3% x x x x
Bursitis postmarketing x x x x x
Neoplasm malignant postmarketing x x x x x x x x x x x
Candida infection postmarketing x x x x x
Carcinoma postmarketing x x x x x x x
Cardiovascular disorder postmarketing x x x x x
Cellulitis postmarketing x x x x x
Chest pain postmarketing, 4% - 6% 1% x x x x x x x x x x x x
Cholestasis postmarketing x x x x x x x
Infection postmarketing, 0% - 24.7% 10% x x x x x x x x x x x x x x x x x
Confusional state postmarketing, uncommon x x x x x x x x x x x x x x x x x x
Conjunctivitis postmarketing x x x x x x x x x x x x
Connective tissue disorder postmarketing x x x x x
Constipation postmarketing x x x x x x x x x x x x
Cough postmarketing, 3% - 5% 4% x x x x
Deafness postmarketing x x x x x
Libido decreased postmarketing x x x x x
Dysphagia postmarketing x x x x x x x x x x x x
Depression postmarketing, 1% - 6% 2% x x x x
Dermatitis postmarketing x x x x x
Diabetes mellitus postmarketing x x x x x
Joint dislocation postmarketing x x x x x
Dizziness postmarketing, 6% - 8% 3% x x x x x x x
Dysgeusia postmarketing x x x x x
Dyspepsia postmarketing, 2.2% - 12% 4% x x x x x x
Dyspnoea postmarketing, 1% - 5% 2% x x x x x
Dysuria postmarketing, 0% - 1% 2% x x x x
Ear disorder postmarketing, 0% - 5% 0% x x x x
Eczema postmarketing x x x x x
Enanthema postmarketing x x x x x
Epistaxis postmarketing x x x x x
Eructation postmarketing x x x x x
Oesophagitis postmarketing x x x x x
Rash postmarketing — 7% - 12% 10% x x x x x x x x x x x
Body temperature increased postmarketing — 0% - 4% 4% x x x x x x x x x x x x x x x x x x
Flatulence postmarketing, 4% - 5% 1% x x x x
Flushing postmarketing — 0% - 5% 2% x x x x x x x x x x x x x x x x x x
Folliculitis postmarketing x x x x x
Fracture postmarketing x x x x x
Gastritis postmarketing x x x x x x x x x x x x
Gastroenteritis postmarketing x x x x x x x
Gastrointestinal disorder postmarketing, 0% - 4% 0% x x x x x x x x x x
Gingival bleeding postmarketing x x x x x
Gingivitis postmarketing, 0% - 4% 1% x x x x
Glossitis postmarketing x x x x x
Goitre postmarketing x x x x x
Cardiac failure postmarketing x x x x x
Haematuria postmarketing x x x x x x x x x x x x
Haemolytic uraemic syndrome rare x x x x x x x x x x x x x x x x
Haemorrhage postmarketing x x x x x
Hepatitis postmarketing x x x x x x x
Herpes simplex postmarketing x x x x x
Herpes zoster postmarketing x x x x x
Hyperbilirubinaemia postmarketing x x x x x
Hyperaesthesia postmarketing x x x x x
Hyperglycaemia rare x x x x x x x x x x x x x x x x x x
Hyperkalaemia postmarketing, common x x x x x x x x x x x
Hypersensitivity postmarketing x x x x x x x x x x x x x
Hypertension postmarketing — 0% - 53% 2% x x x x x x x x x x x x x x x x x x
Hypertrichosis postmarketing — 5.4% - 37.8% 3% x x x x x x x x x x x
Hypertriglyceridaemia postmarketing x x x x x
Salivary gland enlargement postmarketing x x x x x
Hypoaesthesia postmarketing x x x x x
Hypoglycaemia postmarketing x x x x x
Libido increased postmarketing x x x x x
Jaundice postmarketing x x x x x x x
Arthropathy postmarketing, 0% - 5% 0% x x x x
Keratosis postmarketing x x x x x
Nephropathy postmarketing x x x x
Cramps of lower extremities postmarketing, 2% - 12% 1% x x x x
Lethargy postmarketing x x x x x x x x x x x x x x
Progressive multifocal leukoencephalopathy postmarketing x x x x x x
Leukorrhea postmarketing, 0% - 1% 0% x x x x
Breast pain postmarketing x x x x x
Menstrual disorder postmarketing, 1% - 3% 1% x x x x
Myopathy postmarketing, rare x x x x x x
Myocardial infarction postmarketing x x x x x x x x x x x x
Myositis postmarketing x x
Nail disorder postmarketing x x x x x
Neoplasm postmarketing x x x x x x x x x
Nervous system disorder postmarketing x x x x x x x x x x x x x x x x x
Nervousness postmarketing x x x x x
Nightmare postmarketing x x x x x
Nocturia postmarketing x x x x x
Pancreatitis rare x x x x x x x x x x x x x x
Peptic ulcer postmarketing x x x x x x x x x x x x x x x x
Neuropathy peripheral postmarketing x x x x x x x x
Pharyngitis postmarketing, 3% - 5% 4% x x x x x x
Polyuria postmarketing x x x x x
Pruritus postmarketing x x x x x x x x x x x x x x
Psoriasis postmarketing x x
Purpura postmarketing, 2% - 4% 0% x x x x
Thrombotic thrombocytopenic purpura postmarketing x x
Pyelonephritis postmarketing x x x x x
Rhabdomyolysis postmarketing x x
Rhinitis postmarketing, 0% - 5% 0% x x x x
Skin disorder postmarketing x x x x x
Skin ulcer postmarketing, 0% - 1% 2% x x x x
Muscle spasms postmarketing x x x x
Gastric ulcer postmarketing x x x x x
Stomatitis postmarketing, 5% - 7% 8% x x x x
Tinnitus postmarketing, uncommon x x x x x x x x x x x x x x
Tongue disorder postmarketing x x x x x
Tonsillitis postmarketing x x x x x
Tooth disorder postmarketing x x x x x
Upper respiratory tract infection postmarketing, 7.7% - 11.3% x x x x x x
Pollakiuria postmarketing, 2% - 4% 2% x x x x x
Urinary incontinence postmarketing x x x x x
Urinary tract disorder postmarketing x x x x x x x x x
Urticaria postmarketing x x x x x x
Uterine haemorrhage postmarketing x x x x x
Vertigo postmarketing x x x x x
Vestibular disorder postmarketing x x x x x
Weight increased postmarketing — common x x x x x x x x x x x
Weight decreased postmarketing, uncommon x x x x x x x x x x x x x x
Trauma postmarketing, 0% - 4% 0% x x x x
Dry mouth postmarketing x x x x x
Hepatic failure postmarketing x x x x x x x
Micturition urgency postmarketing x x x x x
Mood swings postmarketing x x x x x
Synovial cyst postmarketing x x x x x
Cataract postmarketing x x x x x
Migraine postmarketing, 2% - 3% 1% x x x x x x x x x x
Renal abscess postmarketing x x x x x
Blood urea increased postmarketing x x x x x
Creatinine increased postmarketing, 15.7% - 19.8% x x x x x
Swelling face postmarketing x
Hypomagnesaemia postmarketing — 0% - 6% 0% x x x x x x x x x x x x x x x x x x
Hepatocellular injury postmarketing x x x x x
Muscular weakness postmarketing, rare x x x x x x
Eye pain postmarketing x x x x x x x
Dry skin postmarketing x x x x x
Tendon disorder postmarketing x x x x x
Polyneuropathy rare x x x x
Pustular psoriasis postmarketing
Abnormal chest sounds NOS postmarketing x x x x x
Liver injury postmarketing x x x x x x x
Malnutrition postmarketing x x x x x x x x x
Fatal outcomes postmarketing x x x x x x x x x x x
Red blood cell disorders postmarketing x x x x x
Microangiopathic haemolytic anaemia rare x x x x x x x x x x x x x x x x
Malaise postmarketing x x x x x
Myalgia postmarketing, common x x x x x x x x x x x x x x x x x x
Digestion impaired postmarketing x x x x x x x
Increased appetite postmarketing x x x x x
Muscle contractions involuntary postmarketing, 2% - 12% 1% x x x x
Cerebration impaired postmarketing x x x x x
Peripheral ischaemia postmarketing x x x x x
Urine abnormality postmarketing x x x x x
Bullous eruption postmarketing, 0% - 1% 1% x x x x
Pharyngeal oedema postmarketing x
Swollen tongue postmarketing x
Lung fibrosis interstitial postmarketing x x x x
Rectal haemorrhage postmarketing, 0% - 3% 1% x x x x
Hepatobiliary disease postmarketing x x x x x
Eye swelling postmarketing x
Uraemic syndrome postmarketing x x
Atrophy postmarketing x x x x
Influenza-like symptoms postmarketing, 1% - 9.9% 2% x x x x x x x
Plaque psoriasis postmarketing
Stiffness postmarketing x x x x x
Neuropathy postmarketing x x x x x
Lymphadenopathy postmarketing x x x x x
Heart sounds abnormal postmarketing x x x x x
Nephrotoxicity postmarketing x x x x x x x x x x x x x x x x
Hot flush postmarketing x x x x x
Serum creatinine increased postmarketing x x x x x
Sweating increased postmarketing x x x x x
Hyperuricaemia postmarketing, common x x x x x x x x x x x
Erythrodermic psoriasis postmarketing
Progressive renal failure postmarketing x x x x x
Serum triglycerides increased postmarketing x x x x x
Blood and lymphatic system disorders postmarketing x x x x x
Graft loss postmarketing x x x
Renal graft loss postmarketing x x x
Insomnia postmarketing — 1% - 4% 2% x x x x x x x x x x x
Polyomavirus infections postmarketing x x x x x x x
Unspecified disorder of autonomic nervous system postmarketing x x x x
Abnormal pigmentation postmarketing x x x x x
Fibroadenosis of breast postmarketing x x x x x
Polyomavirus-associated nephropathy postmarketing x x x x x x
Gout attack postmarketing x x x x x
Thrombotic microangiopathy postmarketing x x x x
Somnolence postmarketing x x x x x
Abnormal vision postmarketing x x x x x
Papilloedema very rare, postmarketing x x x x x x
Benign intracranial hypertension very rare, postmarketing x x x x x x
Visual impairment very rare, postmarketing x x x x x x
Skin cancer x x
Cyst x x x x
Gingival disorder
Gingival hypertrophy x x
Hiccups x x x x x x x x x x x x
Hodgkin's disease x x
Hypotrichosis x x
Mediastinal disorder x x
Night sweats x x x x x x x x x x x x
Obstruction x x x x x x x x x x x x
Polyp x x x x
Renal failure x x x x
Acute respiratory distress syndrome x x
Thrombosis x x x x x x x x x x x x
Upper gastrointestinal haemorrhage x x x x x x x x x x x x
Angiopathy x x x x
Burning sensation x x
Hepatic function abnormal x x x x
Hypocholesterolaemia x x x x x x x x x x x x
Lacrimation increased x x
Unspecified disorder of skin and subcutaneous tissue x x x x x
Stomach ache x x
Hyperamylasaemia x x
Function kidney decreased x x x x x x x x x x x x
Hallucination, visual x x
Discomfort x x
Consciousness abnormal x x x x
Anaphylactoid reaction x x x
Vision blurred x x
Sensation of foreign body x x
Gastrointestinal symptom NOS x x
Contraction skeletal muscle x
Stinging x x
Infestation NOS x x x x x
Ear and labyrinth disorders x x
Thrombocytopenic purpura x x
Cyclosporine toxicity x x x x x x x x x x x x
Transplant failure x x x x x x x x x x x x x x
Renal impairment x x
Malignant solid tumour x x
Conjunctival hyperaemia x x
Tingling sensation x x x x x x x x x x x x
Posterior reversible encephalopathy syndrome x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CYCLOSPORINE / RESTASIS

Side effects:8
Source:FDA

cyclosporine

Side effects:16
Source:FDA Structured Product Label

CYCLOSPORINE / APO-CYCLOSPORINE ORAL SOLUTION

Side effects:73
Source:Health Canada

CYCLOSPORINE

Side effects:74
Source:FDA Structured Product Label

CYCLOSPORINE / SANDIMMUNE

Side effects:75
Source:FDA

CYCLOSPORINE

Side effects:77
Source:FDA Structured Product Label

Cyclosporine

Side effects:78
Source:FDA Structured Product Label

NEORAL / Neoral, Soft gelatin capsule

Side effects:82
Source:Medsafe

CYCLOSPORINE

Side effects:85
Source:FDA Structured Product Label

CYCLOSPORINE

Side effects:85
Source:FDA Structured Product Label

CYCLOSPORINE / NEORAL 25MG

Side effects:90
Source:Health Canada

cyclosporin / NEORAL

Side effects:108
Source:medicines.org.au

cyclosporin / SANDIMMUN

Side effects:109
Source:medicines.org.au

CYCLOSPORINE

Side effects:162
Source:FDA Structured Product Label

CYCLOSPORINE / NEORAL

Side effects:211
Source:FDA

CYCLOSPORINE / NEORAL

Side effects:211
Source:FDA

Cyclosporine

Side effects:216
Source:FDA Structured Product Label

CYCLOSPORINE

Side effects:222
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label